{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T09:27:00Z","timestamp":1777800420088,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jad.2026.121511","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:14:56Z","timestamp":1772036096000},"page":"121511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sequenced treatment alternatives to relieve adolescent depression: A pragmatic clinical trial"],"prefix":"10.1016","volume":"404","author":[{"given":"Yuqian","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingjie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueer","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121511_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2005.05.011","article-title":"The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients","volume":"88","author":"Angst","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121511_bb0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.psc.2023.02.007","article-title":"Special populations: treatment-resistant depression in children and adolescents","volume":"46","author":"Ayvaci","year":"2023","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2026.121511_bb0015","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jad.2026.121511_bb0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00004583-199704000-00018","article-title":"The screen for child anxiety related emotional disorders (SCARED): scale construction and psychometric characteristics","volume":"36","author":"Birmaher","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.299.8.901","article-title":"Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial","volume":"299","author":"Brent","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2026.121511_bb0035","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.jad.2026.121511_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2026.121511_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313070","article-title":"Augmentative pharmacological strategies in treatment-resistant major depression: a comprehensive review","volume":"22","author":"Caldiroli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2026.121511_bb0050","article-title":"Guidelines for adolescent depression in primary care (GLAD-PC): part II","volume":"141","author":"Cheung","year":"2018","journal-title":"Treatment and Ongoing Management. Pediatrics."},{"key":"10.1016\/j.jad.2026.121511_bb0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.121511_bb0060","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881115581093","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines","volume":"29","author":"Cleare","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121511_bb0065","article-title":"Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents","volume":"2014","author":"Cox","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2026.121511_bb0070","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2215-0366(21)00034-1","article-title":"Circadian rhythm sleep-wake disturbances and depression in young people: implications for prevention and early intervention","volume":"8","author":"Crouse","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0075","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2215-0366(20)30036-5","article-title":"Treatment outcomes for depression: challenges and opportunities","volume":"7","author":"Cuijpers","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jadohealth.2021.08.026","article-title":"Prevalence of depression among adolescents in the U.S. from 2009 to 2019: analysis of trends by sex, race\/ethnicity, and income","volume":"70","author":"Daly","year":"2022","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.jad.2026.121511_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2215-0366(18)30292-X","article-title":"Early intervention for depression in young people: a blind spot in mental health care","volume":"6","author":"Davey","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0090","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Diseases","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2026.121511_bb0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jcpp.13202","article-title":"Annual research review: defining and treating pediatric treatment-resistant depression","volume":"61","author":"Dwyer","year":"2020","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0100","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/appi.ajp.2010.09040552","article-title":"Treatment of resistant depression in adolescents (TORDIA): week 24 outcomes","volume":"167","author":"Emslie","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"1106\u20131118","key":"10.1016\/j.jad.2026.121511_bb0105","article-title":"Vortioxetine for major depressive disorder in adolescents: 12-week randomized, placebo-controlled, fluoxetine-referenced, fixed-dose study","volume":"61","author":"Findling","year":"2022","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0110","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamapediatrics.2023.3996","article-title":"Estimates of major depressive disorder and treatment among adolescents by race and ethnicity","volume":"177","author":"Flores","year":"2023","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.jad.2026.121511_bb0115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1186\/s12888-023-05221-w","article-title":"Sequenced treatment alternatives to relieve adolescent depression (STAR-AD): a multicentre open-label randomized controlled trial protocol","volume":"23","author":"He","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1176\/ajp.2007.164.4.680b","article-title":"Reactive depression and remission rates in the STAR*D trials","volume":"164","author":"Heath","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/eip.12142","article-title":"Back to basics: could behavioural therapy be a good treatment option for youth depression? A critical review","volume":"9","author":"Hetrick","year":"2015","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0130","article-title":"New generation antidepressants for depression in children and adolescents: a network meta-analysis","volume":"5","author":"Hetrick","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2026.121511_bb0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-244X-13-303","article-title":"Evaluating differential developmental trajectories to adolescent-onset mood and psychotic disorders","volume":"13","author":"Hickie","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2026.121511_bb0140","first-page":"S3","article-title":"Right care, first time: a highly personalised and measurement-based care model to manage youth mental health","volume":"211","author":"Hickie","year":"2019","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.jad.2026.121511_bb0145","article-title":"Reliability and validity of the Chinese version of the children\u2019s depression rating scale-revised (CDRS-R)","volume":"13","author":"Huang","year":"2025","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.jad.2026.121511_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7074","article-title":"Association of Treatment with Antipsychotics, antidepressants, or both with movement disorders and seizures among children and adolescents with depression in Korea","volume":"5","author":"Jeon","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2026.121511_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/WNF.0b013e3182a31f3d","article-title":"Augmentation of aripiprazole for depressed patients with an inadequate response to antidepressant treatment: a 6-week prospective, open-label, multicenter study","volume":"36","author":"Jon","year":"2013","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jad.2026.121511_bb0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.121511_bb0165","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00787-012-0270-0","article-title":"Efficacy and safety of aripiprazole in child and adolescent patients","volume":"21","author":"Kirino","year":"2012","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/CHI.0b013e3181900404","article-title":"Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial","volume":"48","author":"Kryzhanovskaya","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0175","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"Lam","year":"2024","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.121511_bb0180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-244X-14-202","article-title":"Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial","volume":"14","author":"Lazowski","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0185","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa2204462","article-title":"Antidepressant augmentation versus switch in treatment-resistant geriatric depression","volume":"388","author":"Lenze","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.121511_bb0190","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/10503307.2024.2335520","article-title":"Cognitive-behavioral therapy for patients with somatoform disorders: a pilot preliminary randomized controlled trial","volume":"35","author":"Luo","year":"2025","journal-title":"Psychother. Res."},{"key":"10.1016\/j.jad.2026.121511_bb0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/archdischild-2020-320020","article-title":"Depression in children and young people: identification and management NICE guidelines","volume":"107","author":"Luxton","year":"2022","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"key":"10.1016\/j.jad.2026.121511_bb0200","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0706743716659276","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. Special populations: youth, women, and the elderly","volume":"61","author":"MacQueen","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.121511_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.725320","article-title":"Discriminative localized sparse approximations for mass characterization in mammograms","volume":"11","author":"Makrogiannis","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jad.2026.121511_bb0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and new Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0215","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.292.7.807","article-title":"Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for adolescents with depression study (TADS) randomized controlled trial","volume":"292","author":"March","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2026.121511_bb0220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/jama.2017.8036","article-title":"Effect of antidepressant switching vs augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: the VAST-D randomized clinical trial","volume":"318","author":"Mohamed","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2026.121511_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.smrv.2016.05.002","article-title":"The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia","volume":"33","author":"Monti","year":"2017","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.jad.2026.121511_bb0230","series-title":"Depression in Adults: Treatment and Management","author":"NICE","year":"2022"},{"key":"10.1016\/j.jad.2026.121511_bb0235","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jad.2021.12.134","article-title":"Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis","volume":"302","author":"Nunez","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121511_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003946","article-title":"Childhood factors associated with suicidal ideation among south African youth: a 28-year longitudinal study of the birth to twenty plus cohort","volume":"19","author":"Orri","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.jad.2026.121511_bb0245","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.nmd.0000217807.56978.5b","article-title":"Major depression in the transition to adulthood: the impact of active and past depression on young adult functioning","volume":"194","author":"Paradis","year":"2006","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jad.2026.121511_bb0250","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(02)07954-0","article-title":"Suicide rates in China, 1995-99","volume":"359","author":"Phillips","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jad.2026.121511_bb0255","first-page":"979","article-title":"Children\u2019s","volume":"21","author":"Poznanski","year":"1985","journal-title":"Depression Rating Scale - Revised Psychopharmacology bulletin (September 1984)."},{"key":"10.1016\/j.jad.2026.121511_bb0260","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S2215-0366(17)30004-4","article-title":"Adolescent depression and the treatment gap","volume":"4","author":"Rice","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0265","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0270","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4088\/JCP.v66n0407","article-title":"Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients","volume":"66","author":"Sharpley","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.121511_bb0275","first-page":"244","article-title":"Adjunctive atypical antipsychotic treatment for major depressive disorder: a Meta-analysis of depression, quality of life, and safety outcomes","volume":"14","author":"Spielmans","year":"2016","journal-title":"Focus (Am Psychiatr Publ)."},{"key":"10.1016\/j.jad.2026.121511_bb0280","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.euroneuro.2016.03.007","article-title":"A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults","volume":"26","author":"Thase","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121511_bb0285","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med. Care"},{"key":"10.1016\/j.jad.2026.121511_bb0290","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/02698811211013579","article-title":"Efficacy and tolerability of combination treatments for major depression: antidepressants plus second-generation antipsychotics vs. Esketamine vs. Lithium","volume":"35","author":"Vazquez","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121511_bb0295","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.290.8.1033","article-title":"Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials","volume":"290","author":"Wagner","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2026.121511_bb0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13034-024-00766-4","article-title":"Trends and off-label utilization of antipsychotics in children and adolescents from 2016 to 2021 in China: a real-world study","volume":"18","author":"Zhaojian","year":"2024","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"key":"10.1016\/j.jad.2026.121511_bb0305","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","article-title":"Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis","volume":"7","author":"Zhou","year":"2020","journal-title":"Lancet Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726003629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726003629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:28:37Z","timestamp":1777494517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726003629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":61,"alternative-id":["S0165032726003629"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121511","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequenced treatment alternatives to relieve adolescent depression: A pragmatic clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121511"}}